NO175802C - Fremgangsmåte for fremstilling av en lagringsstabil antracyklinglycosidopplösning - Google Patents

Fremgangsmåte for fremstilling av en lagringsstabil antracyklinglycosidopplösning

Info

Publication number
NO175802C
NO175802C NO875055A NO875055A NO175802C NO 175802 C NO175802 C NO 175802C NO 875055 A NO875055 A NO 875055A NO 875055 A NO875055 A NO 875055A NO 175802 C NO175802 C NO 175802C
Authority
NO
Norway
Prior art keywords
anthracycline glycoside
storage stable
preparing
glycoside solution
physiologically acceptable
Prior art date
Application number
NO875055A
Other languages
English (en)
Norwegian (no)
Other versions
NO875055L (no
NO875055D0 (no
NO175802B (no
Inventor
Gaetano Gatti
Diego Oldani
Giuseppe Bottoni
Carlo Confalonieri
Luciano Gambini
Roberto De Ponti
Original Assignee
Erba Farmitalia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26291656&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO175802(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB868629193A external-priority patent/GB8629193D0/en
Application filed by Erba Farmitalia filed Critical Erba Farmitalia
Publication of NO875055D0 publication Critical patent/NO875055D0/no
Publication of NO875055L publication Critical patent/NO875055L/no
Publication of NO175802B publication Critical patent/NO175802B/no
Publication of NO175802C publication Critical patent/NO175802C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO875055A 1986-12-05 1987-12-03 Fremgangsmåte for fremstilling av en lagringsstabil antracyklinglycosidopplösning NO175802C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868629193A GB8629193D0 (en) 1986-12-05 1986-12-05 Injectable ready-to-use solutions
US6465387A 1987-06-22 1987-06-22

Publications (4)

Publication Number Publication Date
NO875055D0 NO875055D0 (no) 1987-12-03
NO875055L NO875055L (no) 1988-06-06
NO175802B NO175802B (no) 1994-09-05
NO175802C true NO175802C (no) 1994-12-14

Family

ID=26291656

Family Applications (1)

Application Number Title Priority Date Filing Date
NO875055A NO175802C (no) 1986-12-05 1987-12-03 Fremgangsmåte for fremstilling av en lagringsstabil antracyklinglycosidopplösning

Country Status (22)

Country Link
EP (4) EP0273603B1 (enExample)
JP (1) JP2621255B2 (enExample)
KR (2) KR0158672B1 (enExample)
CN (1) CN1058391C (enExample)
AT (2) ATE240108T1 (enExample)
AU (1) AU632036B2 (enExample)
BE (1) BE1000540A5 (enExample)
CH (1) CH680494A5 (enExample)
DE (4) DE3751589T2 (enExample)
DK (1) DK175815B1 (enExample)
ES (3) ES2198424T3 (enExample)
FI (1) FI91710C (enExample)
FR (1) FR2607702B1 (enExample)
GB (1) GB2200047B (enExample)
GR (2) GR871846B (enExample)
HK (2) HK39591A (enExample)
IT (1) IT1226072B (enExample)
NL (1) NL8702914A (enExample)
NO (1) NO175802C (enExample)
PT (1) PT86285B (enExample)
SE (1) SE512881C2 (enExample)
SG (1) SG36591G (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8519452D0 (en) * 1985-08-02 1985-09-11 Erba Farmitalia Injectable solutions
DE10300323A1 (de) * 2003-01-09 2004-10-14 Baxter Healthcare S.A. Sicherheitsbehälter mit erhöhter Bruch und Splitterfestigkeit sowie kontaminationsfreier Außenfläche für biologisch aktive Substanzen und Verfahren zu deren Herstellung
CA2446837C (en) * 2001-05-11 2012-01-03 Mitsubishi Pharma Corporation Stable high-concentration injection containing pyrazolone derivative
AU2006213440A1 (en) * 2005-02-11 2006-08-17 Dabur Pharma Limited Stabilized anthracycline glycoside pharmaceutical compositions
BRPI0605832A2 (pt) * 2005-05-11 2009-05-26 Sicor Inc glicosìdeos de antraciclina liofilizados estáveis
BRPI0816364B8 (pt) * 2007-09-04 2021-05-25 Meiji Seika Kaisha solução de injeção, preparação de kit de injeção e injetável para preparar solução de injeção
EP2174651A1 (en) * 2008-10-09 2010-04-14 Charité-Universitätsmedizin Berlin (Charité) A polymer-free hydrogel
CN102614118B (zh) * 2012-03-15 2014-04-30 北京协和药厂 注射用盐酸表柔比星制剂的制备方法及制剂
CN111617030B (zh) * 2020-05-22 2021-09-07 广东药科大学 壳寡糖口服液及其在制备减肥药物中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4177264A (en) * 1977-10-17 1979-12-04 Sri International N-benzyl anthracyclines
GB2007645B (en) * 1977-10-17 1982-05-12 Stanford Res Inst Int Benzyl anthracyclines and pharmaceutical compositions containing them
GB2187311B (en) * 1984-07-27 1988-02-10 Ae Plc Automatic vehicle speed control system
GB8426672D0 (en) * 1984-10-22 1984-11-28 Erba Farmitalia Pharmaceutical compositions
GB8519452D0 (en) * 1985-08-02 1985-09-11 Erba Farmitalia Injectable solutions
JPH0655667A (ja) * 1992-08-06 1994-03-01 Nippon Zeon Co Ltd 複合成形体

Also Published As

Publication number Publication date
FR2607702B1 (fr) 1991-08-16
EP0438183A1 (en) 1991-07-24
HK1011288A1 (en) 1999-07-09
AU632036B2 (en) 1992-12-17
NO875055L (no) 1988-06-06
EP0273603B1 (en) 1992-03-11
ES2198424T3 (es) 2004-02-01
FI91710B (fi) 1994-04-29
NO875055D0 (no) 1987-12-03
DE3777365D1 (de) 1992-04-16
ES2082023T3 (es) 1996-03-16
KR880007086A (ko) 1988-08-26
GR3004303T3 (enExample) 1993-03-31
NL8702914A (nl) 1988-07-01
DE3752368T2 (de) 2004-02-12
ES2039460T3 (es) 1993-10-01
CH680494A5 (enExample) 1992-09-15
SE512881C2 (sv) 2000-05-29
HK1049440A1 (en) 2003-05-16
DE3741037A1 (de) 1988-06-09
BE1000540A5 (fr) 1989-01-24
DE3752368D1 (de) 2003-06-18
DK635287D0 (da) 1987-12-03
GB2200047A (en) 1988-07-27
FI875340A0 (fi) 1987-12-03
EP0438183B1 (en) 1995-11-08
HK39591A (en) 1991-05-31
DK635287A (da) 1988-06-06
KR0158672B1 (en) 1998-12-01
GR871846B (en) 1988-04-01
PT86285A (en) 1988-01-01
FI875340L (fi) 1988-06-06
EP0659435B1 (en) 2003-05-14
JPS63215633A (ja) 1988-09-08
CN87108225A (zh) 1988-09-14
SE8704849D0 (sv) 1987-12-03
IT8722869A0 (it) 1987-12-03
GB2200047B (en) 1990-11-21
AU8205987A (en) 1988-06-09
EP1283044A3 (en) 2003-05-14
ATE129896T1 (de) 1995-11-15
IT1226072B (it) 1990-12-10
EP1283044A2 (en) 2003-02-12
SE8704849L (sv) 1988-06-06
CN1058391C (zh) 2000-11-15
EP0273603A2 (en) 1988-07-06
EP0659435A1 (en) 1995-06-28
SG36591G (en) 1991-06-21
KR960007861B1 (ko) 1996-06-13
FI91710C (fi) 1994-08-10
GB8728313D0 (en) 1988-01-06
DK175815B1 (da) 2005-03-07
FR2607702A1 (fr) 1988-06-10
ATE240108T1 (de) 2003-05-15
PT86285B (pt) 1990-11-07
DE3751589T2 (de) 1996-05-02
EP0273603A3 (en) 1988-07-20
NO175802B (no) 1994-09-05
DE3751589D1 (de) 1995-12-14
JP2621255B2 (ja) 1997-06-18

Similar Documents

Publication Publication Date Title
KR970003057B1 (en) Lyophilized pharmaceutical composition of neocarzinostatin derivative
NO875299D0 (no) Insulinpreparat for ikke-paranteral administrasjon.
FI891338L (fi) Parannus menetelmään 2',3'-dideoksi-2',3'-didehydronukleosidien valmistamiseksi
FI881061A0 (fi) Kompositioner med foerdroejd frigoerelse foer parenteralt bruk och deras anvaendning.
NO160374C (no) Fremgangsmaate for modifisering av alginater (polyuronider) slik at de faar endrede fysikalske egenskaper.
SE8602743L (sv) Bruksferdiga injektionslosningar innehallande en antitumorantracyklinglykosid
FI901328A0 (fi) Menetelmä farmaseuttisesti käyttökelpoisen (7 ,17 )-17-hydroksi-7-metyyli-19-nor-17-pregn-5(10)-en-20-yn-3-onin valmistamiseksi kiteisenä puhtaana muotona
PT86285A (en) Process for the preparation of injectable anthracycline glycoside solutions
PT86619A (pt) Process for preparing alkylmelatonins
ATE82850T1 (de) Verwendung von 2-pyrimidinyl-1-piperazinderivaten.
PT84130A (fr) Procede de preparation de nouveaux derives de 3-alkoxyflavones et de leurs compositions therapeutiques
DE3565535D1 (en) Process for the preparation of optically active 1,4-dihydropyridines
IT1230633B (it) Procedimento per preparare derivati della 1,5 benzotiazepina.
SE9002508D0 (sv) Asymmetric synthesis of furo (3,4-c) pyridine derivatives
BG46747A3 (bg) Метод за получаване на 1,5- бензотиазепинови производни
NO862740D0 (no) Fremgangsmaate for stabilisering av xantangummi i vandig loesning.
KR970005015A (ko) 치환된 2,4-디아미노-5-시아노피리미딘 및 이들 화합물의 제조방법
FR2620449B1 (fr) Procede de preparation de derives de benzodiazepine-1,4 one-2
NO910056L (no) Fremgangsmaate for fremstilling av 2,6-substituert-3,5-pyridindicarboxylsyrederivater.

Legal Events

Date Code Title Description
MK1K Patent expired